News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
193,923 Results
Type
Article (4403)
Company Profile (30)
Press Release (189490)
Multimedia
Podcasts (4)
Webinars (1)
Section
Business (74415)
Career Advice (83)
Deals (12438)
Drug Delivery (10)
Drug Development (22894)
Employer Resources (9)
FDA (3985)
Job Trends (4416)
News (111567)
Policy (7590)
Tag
2027 Pharm Country Standard (1)
Academia (371)
Academic (1)
Accelerated approval (9)
Adcomms (2)
Allergies (62)
Alliances (8877)
ALS (47)
Alzheimer's disease (487)
Antibody-drug conjugate (ADC) (105)
Approvals (4257)
Artificial intelligence (105)
Autoimmune disease (65)
Automation (13)
Bankruptcy (99)
Best Places to Work (4023)
Biosimilars (42)
Biotechnology (17)
Bladder cancer (70)
Brain cancer (16)
Breast cancer (292)
Cancer (1981)
Cardiovascular disease (164)
Career advice (71)
Career pathing (5)
CAR-T (73)
CDC (3)
Cell therapy (193)
Cervical cancer (13)
Clinical research (21746)
Collaboration (447)
Company closure (1)
Compensation (384)
Complete response letters (13)
COVID-19 (559)
CRISPR (31)
C-suite (277)
Cystic fibrosis (41)
Data (3135)
Depression (58)
Diabetes (186)
Diagnostics (1928)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (46)
Drug pricing (21)
Drug shortages (2)
Duchenne muscular dystrophy (75)
Earnings (60116)
Editorial (5)
Employer branding (1)
Employer resources (7)
Events (27107)
Executive appointments (229)
FDA (5427)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (370)
Gene editing (65)
Generative AI (5)
Gene therapy (186)
GLP-1 (242)
Government (702)
Grass and pollen (1)
Guidances (342)
Healthcare (5088)
HIV (27)
Huntington's disease (5)
IgA nephropathy (33)
Immunology and inflammation (82)
Immuno-oncology (12)
Indications (41)
Infectious disease (640)
Inflammatory bowel disease (77)
Inflation Reduction Act (2)
Influenza (43)
Intellectual property (110)
Interviews (11)
IPO (7687)
IRA (4)
Job creations (613)
Job search strategy (61)
JPM (7)
Kidney cancer (8)
Labor market (20)
Layoffs (121)
Leadership (1)
Legal (1484)
Liver cancer (28)
Longevity (1)
Lung cancer (283)
Lymphoma (184)
Machine learning (11)
Management (2)
Manufacturing (181)
MASH (94)
Medical device (4238)
Medtech (4260)
Mergers & acquisitions (5224)
Metabolic disorders (416)
Multiple sclerosis (82)
NASH (8)
Neurodegenerative disease (118)
Neuropsychiatric disorders (34)
Neuroscience (941)
NextGen: Class of 2026 (1238)
Non-profit (669)
Now hiring (6)
Obesity (122)
Opinion (24)
Ovarian cancer (75)
Pain (71)
Pancreatic cancer (92)
Parkinson's disease (99)
Partnered (3)
Patents (194)
Patient recruitment (200)
Peanut (28)
People (9565)
Pharmaceutical (6)
Pharmacy benefit managers (4)
Phase 1 (5940)
Phase 2 (9207)
Phase 3 (8417)
Pipeline (3021)
Policy (22)
Postmarket research (699)
Preclinical (1966)
Press Release (21)
Prostate cancer (92)
Psychedelics (1)
Radiopharmaceuticals (67)
Rare diseases (272)
Real estate (829)
Recruiting (5)
Regulatory (6998)
Reports (12)
Research institute (317)
Resumes & cover letters (9)
Rett syndrome (21)
RNA editing (3)
RSV (26)
Schizophrenia (68)
Series A (41)
Series B (42)
Service/supplier (1)
Sickle cell disease (43)
Special edition (6)
Spinal muscular atrophy (48)
Sponsored (3)
Startups (394)
Stomach cancer (4)
Supply chain (18)
Tariffs (5)
The Weekly (4)
Vaccines (258)
Venture capital (15)
Weight loss (79)
Women's health (30)
Worklife (4)
Date
Today (35)
Last 7 days (196)
Last 30 days (588)
Last 365 days (14640)
2026 (907)
2025 (14732)
2024 (12434)
2023 (14249)
2022 (15023)
2021 (15442)
2020 (14629)
2019 (11549)
2018 (8554)
2017 (9850)
2016 (7839)
2015 (9565)
2014 (7175)
2013 (5389)
2012 (5767)
2011 (6151)
2010 (5754)
Location
Africa (105)
Alabama (41)
Arizona (86)
Arkansas (2)
Asia (10945)
Australia (1198)
California (4768)
Canada (1224)
China (336)
Colorado (209)
Connecticut (222)
Delaware (142)
Europe (25345)
Florida (738)
Georgia (194)
Hawaii (1)
Idaho (14)
Illinois (264)
India (16)
Indiana (334)
Iowa (10)
Japan (212)
Kansas (38)
Kentucky (12)
Louisiana (9)
Maine (48)
Maryland (599)
Massachusetts (3407)
Michigan (124)
Minnesota (243)
Missouri (65)
Montana (11)
Nebraska (3)
Nevada (58)
New Hampshire (26)
New Jersey (1639)
New Mexico (3)
New York (1324)
North Carolina (596)
North Dakota (1)
Northern California (2377)
Ohio (95)
Oregon (10)
Pennsylvania (1003)
Puerto Rico (8)
Rhode Island (10)
South America (201)
South Carolina (31)
Southern California (1965)
Tennessee (62)
Texas (899)
United States (17455)
Utah (135)
Virginia (108)
Washington D.C. (22)
Washington State (374)
Wisconsin (21)
Wyoming (1)
193,923 Results for "31".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Interim Results for the six months ended 31 October 2025
January 29, 2026
·
22 min read
Press Releases
Ipsen – Half year statement – 2025 12 31
January 7, 2026
·
5 min read
Press Releases
Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025
February 4, 2026
·
26 min read
Press Releases
Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025
February 8, 2026
·
12 min read
Press Releases
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025
February 10, 2026
·
13 min read
Press Releases
GenSight Biologics Reports Cash Position as of December 31, 2025, and Provides Business Updates
January 9, 2026
·
4 min read
Press Releases
Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025
February 8, 2026
·
20 min read
Press Releases
Vaxcyte Advances Adult and Infant Programs for VAX-31, a Potential Best-in-Class, Next-Generation Pneumococcal Conjugate Vaccine
January 23, 2026
·
17 min read
Press Releases
Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
January 26, 2026
·
1 min read
Press Releases
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
January 26, 2026
·
4 min read
1 of 19,393
Next
